Understanding the biochemical basis of Alzheimer's disease: A clinical chemistry approach

Abstract

Alzheimer's disease (AD) is a complex neurodegenerative disorder characterized by progressive cognitive decline and memory loss. This study explores the biochemical underpinnings of AD through a clinical chemistry lens, focusing on the alterations in key biomolecules and metabolic pathways associated with the disease. We examine the roles of amyloid-beta peptides, tau protein hyperphosphorylation, and oxidative stress in neuronal damage, alongside their implications for early diagnosis and therapeutic interventions. By analyzing biomarkers in cerebrospinal fluid and plasma, we aim to enhance the understanding of disease mechanisms and improve diagnostic accuracy. Additionally, this approach highlights the potential of targeted therapies that address specific biochemical pathways, paving the way for more effective treatment strategies. Through a comprehensive review of current literature and ongoing research, this study seeks to contribute to the growing body of knowledge surrounding AD and its biochemical foundations, ultimately aiming to facilitate advancements in clinical practice and patient care.